Funding Rounds
Translate Bio Series A round
Translate BioTranslate Bio is a clinical-stage mRNA therapeutics company developing medicines to treat diseases caused by protein or gene dysfunction and vaccines against infectious disease pathogens.
Summary
Stage: Series A
Raised Amount: $20.70M
Raised Date: 2012-01-18